PharmaCyte Biotech, Inc. (PMCB) stock
PMCBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 7/30
$5.37−0.05 (-0.92%)
Close on Nov 18, 2026Market cap $57.65MP/E –Yield –
PharmaCyte Biotech price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
PharmaCyte Biotech's price to book ratio was 0.2× on Nov 11, 2026, against 0.1× a year earlier. Over the last 5 years it ranged from 0.1× to 0.7×, with a median of 0.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.2× | +0.0 |
| 2025 | Dec 31, 2025 | 0.2× | −0.1 |
| 2024 | Dec 31, 2024 | 0.3× | −0.3 |
| 2023 | Dec 29, 2023 | 0.5× | −0.2 |
| 2022 | Dec 30, 2022 | 0.7× | +0.1 |
| 2021 | Dec 31, 2021 | 0.6× | −1.4 |
| 2020 | Dec 31, 2020 | 2.0× | −10.3 |
| 2019 | Dec 31, 2019 | 12.3× | +4.6 |
| 2018 | Dec 31, 2018 | 7.7× | +0.0 |
| 2017 | Dec 29, 2017 | 7.6× | −13.2 |
| 2016 | Dec 30, 2016 | 20.8× | +15.6 |
| 2015 | Dec 31, 2015 | 5.2× | −15.1 |
| 2014 | Dec 31, 2014 | 20.3× | +3.1 |
| 2013 | Dec 31, 2013 | 17.2× | – |
See a number that looks wrong?